Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ketty Peris and Andrea Chiricozzi.
Ketty Peris
Connection Strength
1.759
Andrea Chiricozzi
  1. COVID-19 occurrence in one secukinumab-treated patient affected by hidradenitis suppurativa and systemic lupus erythematosus. Int J Dermatol. 2020 Nov; 59(11):1423-1424.
    View in: PubMed
    Score: 0.904
  2. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry. Allergy. 2021 06; 76(6):1813-1824.
    View in: PubMed
    Score: 0.233
  3. COVID-19 hygiene measures: hand eczema and insights into ACE2 and integrins as key molecules for SARS-CoV-2 cutaneous transmission. Int J Dermatol. 2020 Nov; 59(11):1409-1410.
    View in: PubMed
    Score: 0.226
  4. The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies. J Dermatolog Treat. 2020 Aug 04; 1-5.
    View in: PubMed
    Score: 0.224
  5. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. Expert Opin Biol Ther. 2021 02; 21(2):271-277.
    View in: PubMed
    Score: 0.058
  6. A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2021 Mar; 35(3):e169-e170.
    View in: PubMed
    Score: 0.057
  7. Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy. J Eur Acad Dermatol Venereol. 2020 Dec; 34(12):e770-e772.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.